Triamterene Chemical Structure (Dyrenium 1)
Dyrenium Capsule
Product Images NDC 59212-003
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dyrenium (NDC 59212-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanz Pharma (us) Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Dyrenium 100mg Bl
This is a description of a medication called Dyrenium. The medication comes in capsule form and each capsule contains 100mg of triamterene. It is recommended to take one capsule twice a day after meals, and the prescribing information should be consulted for more details. The medication should be stored in a tight, light-resistant container at a temperature of 15°-30°C (59°-86°F). The NDC number is 59212-003-01, and the manufacturer is Concordia Pharmaceuticals. The medication is distributed by Amdipharm Limited in Dublin, Ireland.*
Dyrenium 50mg Bl
Dyrenium capsules contain 50mg of triamterene and are dispensed in a light-resistant container. The recommended starting dosage is two capsules (100mg) twice a day after meals. The capsules should be stored at 25°C with excursions permitted between 15°-30°C. Dyrenium is manufactured by Concordia Pharmaceuticals in Canada and distributed by Amdipharm Limited in Ireland. For more information, refer to the accompanying prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
